Patent foramen ovale and stroke

Practical Neurology

Volumn 3, Issue 1, 2003, Pages 4-11

  Mas, Jean Louis ^a  

^a CENTRE HOSPITALIER SAINTE ANNE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; CONTRAST MEDIUM; FIBRINOLYTIC AGENT; HEPARIN; WARFARIN;

ANTICOAGULANT THERAPY; BLEEDING DISORDER; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; CONTRAST ENHANCEMENT; DIAGNOSTIC TEST; DISEASE ASSOCIATION; DOPPLER ECHOGRAPHY; DRUG TOLERABILITY; EMBOLECTOMY; FIBRINOLYTIC THERAPY; HEART ANEURYSM; HEART ATRIUM SEPTUM DEFECT; HUMAN; MEDICAL DECISION MAKING; MIDDLE CEREBRAL ARTERY; OPEN HEART SURGERY; PREVALENCE; RECURRENCE RISK; REVIEW; RISK ASSESSMENT; SECONDARY PREVENTION; THROMBOEMBOLISM; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TRANSIENT ISCHEMIC ATTACK; TREATMENT PLANNING; VEIN THROMBOSIS;

EID: 0043173629     PISSN: 14747758     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1474-7766.2003.00112.x     Document Type: Review

References (32)

1. Arquizan C, Coste J, Touboul PJ & Mas JL (2001) Is patent foramen ovale a family trait. A transcranial Doppler sonographic study. Stroke, 32, 1563-6.
2. Berthet K, Lavergne T, Cohen A et al. (2000) Significant association of atrial vulnerability with atrial septal abnormalities in young patients with ischemic stroke of unknown cause. Stroke, 31, 398-403.
3. Bogousslavsky J, Garazi S, Jeanrenaud X, Aebischer N & Van Melle G (1996) for the Lausanne stroke with paradoxal embolism study Group Stroke recurrence in patients with patent foramen ovale. Neurology, 46, 1301-5.
4. Cabanes L, Coste J, Derumeaux G et al. (2002) for the Patent Foramen Ovale and Atrial Septal Aneurysm Study Group Inter- and intra-observer variability in detection of patent foramen ovale and atrial septal aneurysm with transesophageal echocardiography. Journal of the American Society of Echocardiography, 15, 441-6.
5. Cabanes L, Mas JL, Cohen A et al. (1993) Atrial septal aneurysm and patent foramen ovale as risk factors for cryptogenic stroke in patients less than 55 years of age. A study using transesophageal echocardiography. Stroke, 24, 1865-73.
6. De Castro S, Cartoni D, Fiorelli M et al. (2000) Morphological and functional characteristics of patent foramen ovale and their embolic implications. Stroke, 31, 2407-13.
7. Devuyst G, Bogousslavsky J, Ruchat P et al. (1996) Prognosis after stroke followed by surgical closure of patent foramen ovale: a prospective follow-up study with brain MRI and simultaneous transesophageal and transcranial doppler ultrasound. Neurology, 47, 1162-6.
8. Droste DW, Reisener M, Kemeny V et al. (1999) Contrast transcranial doppler ultrasound in the detection of right to left shunts. Stroke, 30, 1014-8.
9. Hagen PT, Scholz DG & Edwards WD (1984) Incidence and size of patent foramen ovale during the first 10 decades of life: an autopsy study of 965 normal hearts. Mayo Clinic Proceedings, 59, 17-20.
10. Hamann GF, Schatzer-Klotz D, Fröhlig G et al. (1998) Femoral injection of echo contrast medium may increase the sensitivity of testing a patent foramen ovale. Neurology, 50, 1423-8.
11. Hart RG, Boop BS & Anderson DC (1995) Oral anticoagulants and intracranial hemorrhage. Facts and Hypotheses Stroke, 26, 1471-7.
12. Hausmann D, Mügge A & Daniel WG (1995) Identification of patent foramen ovale permitting paradoxic embolism. Journal of the American College of Cardiology, 26, 1030-8.
13. Homma S, Di Tullio MR, Sacco RL, Sciacca RR, Smith C & Mohr JP (1997) Surgical closure of patent foramen ovale in cryptogenic stroke. Stroke, 28, 2376-81.
14. Homma S, Sacco RL, Di Tullio MR, Sciacca RR & Mohr JP (2002) for the PFO in Cryptogenic Stroke Study (PICSS) investigators Effect of medical treatment in stroke patients with patent foramen ovale. Patent foramen ovale in cryptogenic stroke study. Circulation, 105, 2625-31.
15. Hung J, Landzberg MJ, Jenkins KJ et al. (2000) Closure of patent foramen ovale for paradoxical emboli: intermediate-term risk of recurrent neurological events following transcatheter device placement. Journal of the American College of Cardiology, 35, 1311-6.
16. Lamy C, Giannesini C, Zuber M et al. (2002) for the Patent Foramen Ovale and Atrial Septal Aneurysm Study Group Clinical and imaging findings in cryptogenic stroke patients with and without patent foramen ovale: the PFO-ASA study. Stroke, 33, 706-11.
17. Lechat P, Mas JL, Lascault G et al. (1988) Prevalence of patent foramen ovale in patients with stroke. New England Journal of Medicine, 318, 1148-52.
18. Martin F, Sanchez PL, Doherty E et al. (2002) Percutaneous transcatheter closure of patent foramen ovale in patients with pardoxical embolism. Circulation, 106, 1121-6.
19. Mas JL (1996) Diagnosis and management of paradoxical embolism and patent foramen ovale. Current Opinion in Cardiology, 11, 519-24.
20. Mas JL, Arquizan C, Lamy C et al. (2001) for the Patent Foramen Ovale and Atrial Septal Aneurysm study Group Recurrent cerebrovascular events associated with patent foramen ovale, atrial septal aneurysm, or both. New England Journal of Medicine, 345, 1740-6.
21. Mas JL & Zuber M (1995) for the french study Group on patent foramen ovale and atrial septal aneurysm Recurrent cerebrovascular events in patients with patent foramen ovale, atrial septal aneurysm, or both and cryptogenic stroke or transient ischemic attack. American Heart Journal, 130, 1083-8.
22. Mohr JP, Thompson JL, Lazar RM et al. (2001) Warfarin-Aspirin Recurrent Stroke Study group. A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke. New England Journal of Medicine, 345, 1444-51.
23. Nedeltchev K, Arnold M, Wahl A et al. (2002) Outcome of patients with cryptogenic stroke and patent foramen ovale. Journal of Neurology, Neurosurgery and Psychiatry, 72, 347-50.
24. Overell JR, Bone I & Lees KR (2000) Interatrial septal abnormalities and stroke. A meta-analysis of case-control studies. Neurology, 55, 1172-9.
25. Ranoux D, Cohen A, Cabanes L, Amarenco P, Bousser MG & Mas JL (1993) Patent foramen ovale: is stroke due to paradoxical embolism? Stroke, 24, 31-4.
26. Schneider B, Hanrath P, Vogel P & MeinertzT (1990) Improved morphologic characterization of atrial septal aneurysm by transesophageal echocardiography: relation to cerebrovascular events. Journal of the American College of Cardiology, 16, 1000-9.
27. Schuchlenz HW, Weihs W, Beitzke A, Stein JI, Gamillscheg A & Rehak P (2002) Transesophageal echocardiography for quantifying size of patent foramen ovale in patients with cryptogenic cerebrovascular events. Stroke, 33, 293-6.
28. Schuchlenz HW, Weihs W, Horner S & Quehenberger F (2000) The association between the diameter of a patent foramen ovale and the risk of cerebrovascular events. American Journal of Medicine, 109, 456-62.
29. Serena J, Segura T, Perez-Ayuso MJ, Bassaganyas J, Molins A & Davalos A (1998) The need to quantify right-to-left shunt in acute ischemic stroke. A case-control study. Stroke, 29, 1322-8.
30. Silver MD & Dorsey JS (1978) Aneurysms of the septum primum in adults. Archives of Pathology and Laboratory Medicine, 102, 62-5.
31. Webster MWI, Chancellor AM, Smith HJ et al. (1988) Patent foramen ovale in young stroke patients. Lancet, 2, 11-2.
32. Windecker S, Wahl A, Chatterjee T et al. (2000) Percutaneous closure of patent foramen ovale in patients with paradoxical embolism. Long-term risk of recurrent thromboembolic events. Circulation, 101, 893-8.